Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Metagenomi, Inc. - Common Stock
(NQ:
MGX
)
4.470
-0.290 (-6.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
253,611
Open
4.740
Bid (Size)
4.060 (1)
Ask (Size)
5.570 (1)
Prev. Close
4.760
Today's Range
4.070 - 5.100
52wk Range
3.340 - 12.74
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
METAGENOMI ALERT: Bragar Eagel & Squire, P.C. is Investigating Metagenomi, Inc. on Behalf of Metagenomi Stockholders and Encourages Investors to Contact the Firm
July 18, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
July 18, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
Performance
YTD
-56.64%
-56.64%
1 Month
+24.86%
+24.86%
3 Month
-33.08%
-33.08%
6 Month
-56.64%
-56.64%
1 Year
-56.64%
-56.64%
More News
Read More
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX)
July 17, 2024
From
Kirby McInerney LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
July 17, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
July 16, 2024
From
Law Offices of Frank R. Cruz
Via
Business Wire
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
May 29, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
May 14, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
May 02, 2024
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Thursday's Intraday Session
May 02, 2024
Via
Benzinga
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
May 02, 2024
Via
InvestorPlace
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
May 01, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 19, 2024
Via
Benzinga
Metagenomi to Present at Upcoming Scientific Meetings
April 08, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
March 27, 2024
From
Metagenomi, Inc.
Via
GlobeNewswire
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
February 29, 2024
From
Metagenomi Technologies, LLC
Via
GlobeNewswire
This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet
February 19, 2024
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
Metagenomi Announces Closing of Initial Public Offering
February 13, 2024
From
Metagenomi Technologies, LLC
Via
GlobeNewswire
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
February 11, 2024
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.